Madrigal Pharmaceuticals, Inc. <MDGL.O>: Citigroup Initiates Coverage With Buy Rating; Price Target $725
MDGL•Related News
General Mills Q1 Adjusted EPS USD 0.75 Vs. IBES Estimate USD 0.72
GIS•
Veeva wins Vault CRM commitment from another top-20 biopharma company
VEEV•
Amrize <AMRZ.N>: Deutsche Bank cuts target price to $56 from $64
AMRZ•
RPM to acquire Italy waterproofing solutions maker Volteco for Tremco unit
RPM•
Morning News Call - U.S., September 23
SPY•